Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
25 studies found for:    " July 21, 2010":" August 20, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" July 21, 2010":" August 20, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+
Condition: HIV Seropositivity
Interventions: Other: ARV's + Placebo;   Drug: Naltrexone;   Drug: Naltrexone + ARV's
2 Withdrawn A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Drug: Raltegravir plus Truvada;   Drug: Atripla
3 Completed Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Circumcision, Male;   Patient Compliance;   Cellular Phone
Intervention: Other: Text Message
4 Completed Reducing HIV in Adolescents
Condition: HIV Infections
Interventions: Behavioral: Cash incentives;   Behavioral: Life skills curriculum
5 Completed Impact of Nutrition Intervention on HIV/AIDS Infected Patients
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Interventions: Dietary Supplement: Theragran-M; Ensure Plus;   Dietary Supplement: Theragran-M
6 Completed KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
Condition: Antiretroviral Therapy in HIV-1 Infected Children
Interventions: Drug: Kaletra dosed once daily;   Drug: kaletra dosed twice daily
7 Unknown † A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Conditions: HIV Infection;   Gastrointestinal Symptoms
Interventions: Dietary Supplement: GanedenBC30, GBI-30, PTA-6086;   Drug: Placebo
8 Unknown † HIV Indicator Diseases Survey Across Europe - UK Arm
Conditions: HIV;   AIDS;   Indicator Diseases/Indicator Conditions
Interventions: Other: HIV test (serological or salivary);   Other: Interview
9 Unknown † Chronic HIV Infection and Aging in NeuroAIDS (CHAIN)
Conditions: HIV;   Aging
Intervention: Other: Observational
10 Recruiting HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
Conditions: HIV;   Sexually Transmitted Diseases
Interventions: Behavioral: STYLEnS;   Behavioral: Health Promotion
11 Completed Computer-Assisted Tailored Cue-card Health [CATCH] Study
Conditions: Human Immunodeficiency Virus;   STDs;   Hepatitis, Viral, Human
Intervention: Behavioral: Tailored Cue Cards
12 Completed Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population
Condition: Human Immunodeficiency Virus
Interventions: Drug: tenofovir/emtricitabine/efavirenz (TDF/FTC/EFV);   Drug: tenofovir/emtricitabine (TDF/FTC);   Drug: Atazanavir (ATV);   Drug: Ritonavir;   Procedure: Phlebotomy
13 Terminated Intrauterine Insemination In HIV-Discordant Couples
Conditions: HIV-1;   Fertility;   Infertility
Intervention: Other: Sperm Washing with Intrauterine Insemination (IUI)
14 Completed
Has Results 		A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
Conditions: Hepatitis C Infection;   HIV Infection
Intervention: Drug: Nitazoxanide With Pegylated Interferon And Ribavirin
15 Active, not recruiting Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial
Condition: HIV-1
Intervention: Genetic: OZ1 transduced cells
16 Active, not recruiting A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
Condition: HIV-1 Infection
Intervention: Biological: JS7 plasmid DNA and MVA62B vaccine
17 Unknown † Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation
Condition: HIV-1
Intervention:
18 Active, not recruiting Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa
Condition: HIV
Intervention: Behavioral: Health System Navigator
19 Terminated
Has Results 		Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection
Conditions: Hepatitis C;   HIV
Intervention:
20 Completed Russian Labor Migrant HIV Prevention Trial
Condition: HIV
Intervention: Behavioral: Social Network Intervention
To Top

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
† Indicates status has not been verified in more than two years